Literature DB >> 30877703

Pure or Complex Hereditary Spastic Paraplegia Type 4?

Josef Finsterer1.   

Abstract

Entities:  

Year:  2019        PMID: 30877703      PMCID: PMC6444139          DOI: 10.3988/jcn.2019.15.2.265

Source DB:  PubMed          Journal:  J Clin Neurol        ISSN: 1738-6586            Impact factor:   3.077


× No keyword cloud information.
Dear Editor, We read with interest the article by Yang et al.1 about a 45-year-old male with hereditary spastic paraplegia (HSP) due to the mutation c.1413A>G in SPAST. Below we present our comments and concerns about their study. It is interesting that the reported patient did not present with muscle weakness but only isolated lower limb spasticity.1 In addition to spasticity and muscle weakness, pure forms of HSP may also present with sensory disturbances or urinary dysfunction. Readers should therefore have been informed about whether the reported patient developed muscle weakness, bladder dysfunction, or sensory disturbances as the disease progressed during follow-up. HSP type 4 (HSP4) may present as either the pure or complex form of HSP. Manifestations in addition to those found in pure forms of HSP4 include tremor,2 neuropathy,3 epilepsy,4 upper limb spasticity, ataxia,5 white-matter lesions,6 cognitive impairment,6 an abnormal rear skull pit, and recurrent stillbirths. Although the patient presented with the pure form on admission, it should also have been reported whether he developed any of these features during long-term follow-up. HSP therapy is usually symptomatic and particularly directed toward the application of physiotherapy, use of walking aids, and administration of antispastics, anticholinergics for bladder dysfunction, and antiepileptic drugs in the case of epilepsy. The types of treatment that were recommended to the patient should have been reported, as well as their effectiveness. Since the mother of the index case presented with a phenotype similar to that of her son and carried the same mutation, it is another item of missing information whether she developed a complex type of HSP4 during follow-up, as age at onset of the clinical manifestations was the same in both patients. Lastly, it should be mentioned that at least SPG1 to SPG79 (i.e., not only to SPG72) have been identified thus far, and that >65 HSP proteins (i.e., not only 50) have been detected.78 Overall, this interesting case report would have been more meaningful if long-term follow-up data had been provided, as well as the therapeutic measures applied to the index case and his mother.
  8 in total

1.  SERAC1 deficiency causes complicated HSP: evidence from a novel splice mutation in a large family.

Authors:  Benjamin Roeben; Rebecca Schüle; Susanne Ruf; Benjamin Bender; Bader Alhaddad; Tanja Benkert; Thomas Meitinger; Selina Reich; Judith Böhringer; Claus-Dieter Langhans; Frédéric M Vaz; Saskia B Wortmann; Thorsten Marquardt; Tobias B Haack; Ingeborg Krägeloh-Mann; Ludger Schöls; Matthis Synofzik
Journal:  J Med Genet       Date:  2017-09-15       Impact factor: 6.318

2.  Hereditary spastic paraplegia with cerebellar ataxia: a complex phenotype associated with a new SPG4 gene mutation.

Authors:  J E Nielsen; B Johnsen; P Koefoed; K H Scheuer; M Grønbech-Jensen; I Law; K Krabbe; A Nørremølle; H Eiberg; H Søndergård; M Dam; J F Rehfeld; C Krarup; O B Paulson; L Hasholt; S A Sørensen
Journal:  Eur J Neurol       Date:  2004-12       Impact factor: 6.089

3.  Hereditary spastic paraplegia due to SPAST mutations in 151 Dutch patients: new clinical aspects and 27 novel mutations.

Authors:  S T de Bot; R T M van den Elzen; A R Mensenkamp; H J Schelhaas; M A A P Willemsen; N V A M Knoers; H P H Kremer; B P C van de Warrenburg; H Scheffer
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-06-20       Impact factor: 10.154

4.  Peripheral neuropathy in hereditary spastic paraplegia due to spastin (SPG4) mutation--a neurophysiological study using excitability techniques.

Authors:  Kishore R Kumar; Carolyn M Sue; David Burke; Karl Ng
Journal:  Clin Neurophysiol       Date:  2011-12-21       Impact factor: 3.708

5.  Identification of a novel mutation in the spastin gene (SPG4) in an Italian family with hereditary spastic paresis.

Authors:  M Bertelli; S Cecchin; L Lorusso; V Sidoti; A Fabbri; C Lapucci; A Buda; M Pandolfo
Journal:  Panminerva Med       Date:  2006-09       Impact factor: 5.197

6.  Mental deficiency in three families with SPG4 spastic paraplegia.

Authors:  Pascale Ribaï; Christel Depienne; Estelle Fedirko; Anne-Catherine Jothy; Caterine Viveweger; Valérie Hahn-Barma; Alexis Brice; Alexandra Durr
Journal:  Eur J Hum Genet       Date:  2007-10-24       Impact factor: 4.246

Review 7.  JASPAC: Japan Spastic Paraplegia Research Consortium.

Authors:  Kishin Koh; Hiroyuki Ishiura; Shoji Tsuji; Yoshihisa Takiyama
Journal:  Brain Sci       Date:  2018-08-13

8.  Novel Pathogenic Variant of SPAST (c.1413+4A>G) in a Patient with Hereditary Spastic Paraplegia.

Authors:  Jiwon Yang; Ja Young Seo; Kwang Woo Lee; Hyeon Mi Park
Journal:  J Clin Neurol       Date:  2018-10-26       Impact factor: 3.077

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.